Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Thromb Haemost. 2021 Jan 22;19(3):689–700. doi: 10.1111/jth.15209

Table I.

Inhibition potency of warfarin and VK-M-COT for VKOR mutations

VKOR IC50 ± standard deviation (nM)
VK-M-COT Warfarin
Wild type 616 ± 74 5.9 ± 0.6
A26P 487 ± 75 360 ± 33
F55A 249 ± 66 2460 ± 235
W59R 615 ± 101 498 ± 37
L128R 575 ± 132 416 ± 49
Y139F 658 ± 54 633 ± 67